What does Pinealon do? Benefits and evidence
A peptide with unproven brain benefits and no established injection dose.
Also called: EDR, Glu-Asp-Arg, glutamyl-aspartyl-arginine.
Khavinson bioregulator peptides · Synthetic tripeptide studied for nerve-cell protection.
Pinealon is a three-amino-acid peptide studied for brain function and aging. Small oral studies often combined peptides; no independent trial confirms a benefit. Cell and rat findings do not prove better memory, sleep or longer life. Injection dosing, long-term harms and product quality remain unclear.
- Studied in small reports of people with brain symptoms and for work performance, but the benefit is still uncertain. (Studied in a trial)
- In an older study without a comparison group, work and health scores changed after people took it by mouth; the cause is unclear. (Studied in a trial)
- One user reported better focus and libido; for sleep, people report both better and more broken sleep. (Reported by users)
Uses in the sources
- Studied in small reports of brain symptoms and work performance; benefit remains uncertain. (Studied in a trial) (source)
- Users report both better sleep and disrupted sleep. A reliable sleep benefit has not been established. (Reported by users) (source)
- Used for aging claims; human lifespan extension has not been demonstrated. (Reported by users) (source)
Related to Pinealon
- Epitalon: A peptide with telomerase effects in cells, but no proof that people live longer.
- Thymalin: A calf thymus extract studied for immune problems, with uncertain safety and product identity.
- Thymogen: A Russian peptide used for immune problems, with negative cancer trials.
- Vesugen: An experimental blood-vessel peptide with unclear benefits and poorly defined safety.
- Cortagen: A four-amino-acid brain peptide backed mainly by animal work and unverified patent claims.
- DSIP: An experimental sleep peptide with small, mixed human studies and no FDA-approved dose.
Sources
- 503B Bulk Drug Substances List, FDA · FDA · 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2026
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, FDA · FDA · 2026
- July 23-24, 2026, Meeting of the Pharmacy Compounding Advisory Committee – FDA Briefing Document for Epitalon-Related Bulk Drug Substances (Epitalon (free base) and Epitalon acetate), FDA · 2026
- Medicines, European Medicines Agency · European Medicines Agency · 2026
- MHRA Products | Home, MHRA · MHRA · 2026
- Peptide products, Therapeutic Goods Administration · TGA · 2026
- Risks of buying peptide products online, Therapeutic Goods Administration · 2026
- Sepsis, NHS · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026, Australian Government · Australian Government · 2026
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you, Health Canada · Health Canada · 2026
- Anaphylaxis, NHS · NHS · 2023
- Using intramuscular injections in people on oral anticoagulants, NHS Specialist Pharmacy Service · NHS Specialist Pharmacy Service · 2023
- Preventing Unsafe Injection Practices, Centers for Disease Control and Prevention
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.